Immunophotonics
PrivateLast Round
Series C
Sep 1, 2026
Total Funding Raised
$29.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Immunophotonics operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Debt round in February 2024.
Immunophotonics is a biotechnology company that develops novel immunostimulatory drugs designed to enhance routine tumor destruction treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunophotonics Comparables
Compare Immunophotonics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rampart Health | 86% | |
| Ankyra Therapeutics | 84% | |
| Highlight Therapeutics | 82% |
For institutional investors. Book with your work email.
Immunophotonics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 1, 2026 | ||||
| Debt | Feb 29, 2024 | ||||
| Early Funding | Jan 6, 2023 | ||||
| Grant | Oct 25, 2022 | ||||
| Series B | Apr 6, 2022 | ||||
Grant | Feb 17, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immunophotonics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Zubizoom Investments | Series B |
| iSelect Fund | Series B |
| Arch Grants | Grant |
| Cultivation Capital | Series A |
| Missouri Technology Corporation | Series A |
| St. Louis Arch Angels | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
$10M round raised.
- Apr 18, 2026
Monthly visitors grew 58% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 1, 2026
Immunophotonics, Inc. received financing of $10M in Series C on Sep 1st '26.
- hiresSep 1, 2026
Immunophotonics, Inc. promotes Robert H. Arch, Ph.D., from President to President and Chief Executive Officer effective Sep 1st '26 in Missouri, as Miguel Zubizarreta steps down as CEO and continues on the board.
- promotesSep 1, 2026
Effective Sep 1st '26, Immunophotonics, Inc. promotes Robert Arch, Ph.D., from President to President and Chief Executive Officer in Missouri.
For institutional investors. Book with your work email.
Immunophotonics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immunophotonics's valuation, stock price, and market status.
Is Immunophotonics a public or private company?
Immunophotonics is a private company.
What is the current stock price of Immunophotonics?
Immunophotonics is a private company, so its shares have no public market price. Caplight tracks Immunophotonics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immunophotonics worth (valuation)?
Valuation information for Immunophotonics is not publicly available.
Can I buy Immunophotonics stock?
Immunophotonics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immunophotonics's last funding round?
Immunophotonics's most recent funding round was Series C on September 1, 2026.
Who are the main investors in Immunophotonics?
Key investors in Immunophotonics include Zubizoom Investments, Cultivation Capital, BioGenerator Ventures.
Will Immunophotonics IPO soon?
No public IPO plans have been announced for Immunophotonics.
How can I track Immunophotonics secondary market activity?
Caplight tracks bids, offers, and trades in Immunophotonics's shares on secondary markets.